{
    "organizations": [],
    "uuid": "4bf93ebc00cfd9740bc06d12fc248a37ea4c068f",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-bod-australia-updates-on-approval/brief-bod-australia-updates-on-approval-for-clinical-trials-idUSFWN1S71EL",
    "ord_in_thread": 0,
    "title": "BRIEF-BOD Australia Updates On Approval For Clinical Trials",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 1 (Reuters) - BOD Australia Ltd:\n* HUMAN RESEARCH ETHICS COMMITTEE GRANTED CO FULL ETHICS APPROVAL TO BEGIN CANNABIS PHASE I CLINICAL TRIALS Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-01T07:51:00.000+03:00",
    "crawled": "2018-05-01T20:12:05.014+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "bod",
        "australia",
        "ltd",
        "human",
        "research",
        "ethic",
        "committee",
        "granted",
        "co",
        "full",
        "ethic",
        "approval",
        "begin",
        "cannabis",
        "phase",
        "clinical",
        "trial",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}